Section R4-23-674. Limited-service Long-term Care Pharmacy

A.      A limited-service pharmacy permittee shall ensure that the limited-service long-term care pharmacy complies with:

1.        The general requirements of R4-23-671;

2.        The professional practice standards of Article 4 and Arti- cle 11; and

3.        The permits and drug distribution standards of R4-23-606 through R4-23-612, R4-23-670, and this Section.

B.       If a limited-service long-term care pharmacy permittee con- tracts with a long-term care facility as a Provider Pharmacy, as defined in R4-23-110, the limited-service long-term care phar- macy permittee shall ensure that the long-term care consultant pharmacist and the pharmacist-in-charge of the limited-service long-term care pharmacy comply with R4-23-701, R4-23- 701.01, R4-23-701.02, R4-23-701.03, R4-23-701.04, and this Section.

C.      The limited-service long-term care pharmacy permittee or pharmacist-in-charge shall ensure that prescription medication is delivered to the patient’s long-term care facility or locked in the dispensing area of the pharmacy when a pharmacist is not present in the pharmacy.

D.      The pharmacist-in-charge of a limited-service long-term care pharmacy shall authorize only those individuals listed in R4- 23-610(B) to be in the limited-service long-term care phar- macy.

E.       In consultation with the long-term care facility’s medical director and director of nursing, the long-term care consultant pharmacist and pharmacist-in-charge of the long-term care facility’s provider pharmacy may develop, if necessary, a med- ication formulary for the long-term care facility that ensures the safe and efficient procurement, dispensing, distribution,

administration, and control of drugs in the long-term care facility.

F.       The limited-service long-term care pharmacy permittee or pharmacist-in-charge shall ensure that the written policies and procedures required in R4-23-671(E) include the following:

1.        Clinical services and drug utilization management for:

a.         Drug utilization reviews,

b.        Inventory audits,

c.         Patient outcome monitoring,

d.        Drug information, and

e.         Education of pharmacy and other health profession- als;

2.        Controlled substances;

3.        Drug compounding, dispensing, and storage;

4.        Drug delivery requirements for:

a.         Transportation,

b.        Security,

c.         Temperature and other environmental controls, and

d.        Emergency provisions;

5.        Drug product procurement;

6.        Duties  and  qualifications   of  professional  and  support staff;

7.        Emergency drug supply unit procedures;

8.        Formulary, including development, review, modification, use, and documentation, if applicable;

9.        Patient profiles;

10.     Patient education;

11.     Prescription orders, including:

a.         Approved abbreviations,

b.        Stop-order procedures, and

c.         Leave-of-absence and discharge prescription order procedures;

12.     Quality management procedures for:

a.         Adverse drug reactions,

b.        Drug recalls,

c.         Expired and beyond-use-date drugs,

d.        Medication or dispensing errors, and

e.         Education of professional and support staff;

13.     Recordkeeping;

14.     Sanitation; and

15.     Security.

Historical Note

New Section made by final rulemaking at 9 A.A.R. 1064, effective May 4, 2003 (Supp. 03-1). Amended by final

rulemaking at 10 A.A.R. 1192, effective May 1, 2004 (Supp. 04-1). Amended by final rulemaking at 19 A.A.R.

2894, effective November 10, 2013 (Supp. 13-3).